Traction for its specialty portfolio, a strong showing in the domestic market, and better regulatory compliance are positives for the country’s largest pharmaceutical (pharma) company, Sun......
Indian pharmaceutical firms foresee minimal disruptions in trade with Israel despite escalating regional tensions. Photograph: Yves Herman/Reuters Rising crude prices and export shipping insurance......
Sun Pharmaceutical Industries (Sun Pharma) reported a turnaround in the January-March quarter of the 2022-23 financial year (Q4FY23), declaring a profit after tax (PAT) of Rs 1,984 crore versus a......
Suraksha started by funding developers for projects, and then evolved into realty angel investing. Dev Chatterjee reports. IMAGE: Suraksha Smart City - Vasai-Virar's biggest township under......
The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015 Investors......